Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Verrucas. Guidelines for management.

J A Leman1, E C Benton

  • 1Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh, Scotland.

American Journal of Clinical Dermatology
|November 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT).

The British journal of dermatology·2021
Same author

Measuring the societal impact of psoriasis in the United Kingdom through a non-interventional study of patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.

Clinical and experimental dermatology·2016
Same author

Psoriasis: are clinicians too busy to assess disease severity?

BMJ (Clinical research ed.)·2014
Same author

Beware the blistering patient with dysphonia.

Clinical and experimental dermatology·2013
Same author

Painful ulceration of the lower legs in a young woman.

Clinical and experimental dermatology·2013
Same journal

Defining the Potential for Disease Modification in Atopic Dermatitis.

American journal of clinical dermatology·2026
Same journal

Atopic Dermatitis: New Targets and Emerging Systemic Therapies.

American journal of clinical dermatology·2026
Same journal

Rethinking Head and Neck Atopic Dermatitis: Pathogenic Axes and Emerging Therapeutic Directions.

American journal of clinical dermatology·2026
Same journal

Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

American journal of clinical dermatology·2026
Same journal

A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa.

American journal of clinical dermatology·2026
Same journal

What's New in Photoprotection?

American journal of clinical dermatology·2026
See all related articles

Human papillomavirus (HPV) infections are common, but treatments for warts can be difficult. Current therapies vary in effectiveness, with no single method being universally successful for viral warts.

Area of Science:

  • Dermatology
  • Virology

Background:

  • Human papillomavirus (HPV) infections are highly prevalent, affecting most individuals during their lifetime.
  • Diagnosis of HPV-related conditions, such as warts, is typically straightforward via clinical examination.

Purpose of the Study:

  • To review the challenges and current treatment modalities for human papillomavirus (HPV) infections.
  • To discuss indications for treatment, factors influencing clearance rates, and the spectrum of available therapeutic options.

Main Methods:

  • Review of existing literature on human papillomavirus (HPV) diagnosis and treatment.
  • Categorization of treatment approaches including destructive, antimitotic, immune-stimulating, and virucidal agents.
  • Analysis of factors affecting treatment efficacy and patient outcomes.

Related Experiment Videos

Main Results:

  • Treatment for HPV-induced warts presents challenges, with varying clearance rates influenced by patient age and infection duration.
  • A wide array of treatments exist, including destructive methods, antimitotics, immune stimulants, and virucidal agents, none offering a universally effective solution.
  • Spontaneous resolution occurs, and for treated cases, simpler, well-tolerated therapies are recommended initially.

Conclusions:

  • There is currently no single, highly effective treatment for viral warts caused by human papillomavirus (HPV).
  • Future research should focus on developing specific, safe, effective, and affordable antiviral agents for HPV.
  • Personalized treatment strategies, starting with less invasive options, are advisable for patients seeking intervention for HPV warts.